The Signal Expert insights and opinions on clinical research and drug development. Expert insights and opinions on clinical research and drug development. Category: Scientific Advisory 11 Perspectives on the Present and Future of Clinical Development April 13, 2023 Signant Health Posted in Scientific Advisory The clinical trial landscape continues to undergo rapid transformation, spurred by shifting industry paradigms and evolving regulatory guidance, among other… Read More ISCTM 2022: Scientific Posters Compilation September 19, 2022 Signant Health Posted in Scientific Advisory Signant’s neuroscience team and CNS experts presented scientific posters at the 2022 Autumn Conference hosted by the International Society for… Read More AAIC 2022: Scientific Posters Compilation August 19, 2022 Signant Health Posted in Scientific Advisory Signant’s neuroscience team and CNS experts presented scientific posters at the 2022 Alzheimer’s Association International Conference in San Diego, California,… Read More Get to Know the SME – Lew Fredane August 2, 2022 Signant Health Posted in Scientific Advisory Were you always interested in neurology? If not, what did you originally want to be and why? Not at all –… Read More With Sensors and Wearables, It’s Not All About the Hardware July 13, 2022 Cristina Rhoads Posted in eCOA The rapid adoption and incorporation of technology into many aspects of clinical research enables new opportunities to improve drug development…. Read More ASCP 2022: Scientific Posters Compilation June 30, 2022 Signant Health Posted in Scientific Advisory Signant’s psychiatry experts and CNS thought leaders presented scientific posters at the American Society of Clinical Psychopharmacology’s 2022 annual meeting… Read More Get to Know the SME: Manuela Bossi May 19, 2022 Signant Health Posted in Scientific Advisory My scientific background is in psychology, and I have years of clinical research experience. I have always been driven by the… Read More Signant Health’s Clinical Scientist Jennifer Olt Receives ISCTM New Investigator Award May 11, 2022 Signant Health Posted in Scientific Advisory Jennifer Olt, Ph.D., a Clinical Scientist from Signant Health’s Operations – Clinical Science team, accepted a 2022 New Investigator Award… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More 1 2 Next
Category: Scientific Advisory 11 Perspectives on the Present and Future of Clinical Development April 13, 2023 Signant Health Posted in Scientific Advisory The clinical trial landscape continues to undergo rapid transformation, spurred by shifting industry paradigms and evolving regulatory guidance, among other… Read More ISCTM 2022: Scientific Posters Compilation September 19, 2022 Signant Health Posted in Scientific Advisory Signant’s neuroscience team and CNS experts presented scientific posters at the 2022 Autumn Conference hosted by the International Society for… Read More AAIC 2022: Scientific Posters Compilation August 19, 2022 Signant Health Posted in Scientific Advisory Signant’s neuroscience team and CNS experts presented scientific posters at the 2022 Alzheimer’s Association International Conference in San Diego, California,… Read More Get to Know the SME – Lew Fredane August 2, 2022 Signant Health Posted in Scientific Advisory Were you always interested in neurology? If not, what did you originally want to be and why? Not at all –… Read More With Sensors and Wearables, It’s Not All About the Hardware July 13, 2022 Cristina Rhoads Posted in eCOA The rapid adoption and incorporation of technology into many aspects of clinical research enables new opportunities to improve drug development…. Read More ASCP 2022: Scientific Posters Compilation June 30, 2022 Signant Health Posted in Scientific Advisory Signant’s psychiatry experts and CNS thought leaders presented scientific posters at the American Society of Clinical Psychopharmacology’s 2022 annual meeting… Read More Get to Know the SME: Manuela Bossi May 19, 2022 Signant Health Posted in Scientific Advisory My scientific background is in psychology, and I have years of clinical research experience. I have always been driven by the… Read More Signant Health’s Clinical Scientist Jennifer Olt Receives ISCTM New Investigator Award May 11, 2022 Signant Health Posted in Scientific Advisory Jennifer Olt, Ph.D., a Clinical Scientist from Signant Health’s Operations – Clinical Science team, accepted a 2022 New Investigator Award… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More 1 2 Next